RBAKDN
RBAK downstream neighbor protein
Also known as: RAKDN_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for RBAKDN in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
81 residues, UniProt reviewed canonical sequence.
>A6NC62|RBAKDN
1 MWPPLLLLLL LLPAAPVPTA KAAPHPDANT QEGLQNLLQG VGAGGDGELR ADSHLAPGSG
61 CIDGAVVATR PESRGGRPAV PLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RBAKDN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.62
OntologyGO
Cellular components
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RBAKDN as an antibody target. Whether an autoantibody or antibody against RBAKDN could matter depends on whether native RBAKDN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RBAKDN is annotated as secreted, so native RBAKDN circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label RBAKDN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...